What is the role of the Ceruloplasmin (CP) test in diagnosing Wilson's disease in patients with unexplained liver disease, neurological symptoms, or psychiatric issues, particularly those with a family history of the condition?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceruloplasmin Testing in Wilson's Disease

Serum ceruloplasmin should be routinely measured in all patients aged 3-55 years with unexplained liver disease, neurological symptoms, or psychiatric abnormalities, but a normal ceruloplasmin level does NOT exclude Wilson's disease and requires additional diagnostic testing. 1

Critical Diagnostic Limitations

The ceruloplasmin test has significant limitations that every clinician must understand:

  • 15-36% of children with Wilson's disease have ceruloplasmin in the normal range 2
  • Up to 50% of patients with hepatic Wilson's disease may have low-normal ceruloplasmin levels 2
  • In one series, 22% of Wilson's disease patients (12 of 55) had normal ceruloplasmin AND no Kayser-Fleischer rings 2
  • The positive predictive value of low ceruloplasmin alone is only 5.9-6%, meaning most patients with low ceruloplasmin do NOT have Wilson's disease 1, 2, 3

When to Order Ceruloplasmin

Order ceruloplasmin testing in these specific clinical scenarios:

Hepatic Presentations

  • Unexplained elevated aminotransferases at any age 3-55 years 1, 2
  • Isolated hepatomegaly or fatty liver of unknown cause 2
  • Cirrhosis without clear etiology 2
  • Fulminant hepatic failure 2, 4
  • Autoimmune hepatitis failing standard immunosuppressive therapy 2

Neurological Presentations

  • Tremor, dystonia, dysarthria, or drooling 1, 2
  • Movement disorders or coordination problems 2
  • Deteriorating handwriting (micrographia) 1
  • Behavioral deterioration or declining school performance 1

Psychiatric Presentations

  • Depression, anxiety, or personality changes with ANY liver abnormality 1, 2
  • Frank psychosis in young adults 1

Other Presentations

  • Unexplained Coombs-negative hemolytic anemia with liver dysfunction 2, 4
  • First-degree relatives of confirmed Wilson's disease patients 2

Interpreting Ceruloplasmin Results

Extremely Low Levels (<50 mg/L or <5 mg/dL)

  • Provides strong evidence for Wilson's disease and warrants immediate comprehensive evaluation 1, 2

Modestly Low Levels (<200 mg/L or <20 mg/dL but >50 mg/L)

  • Suggests further evaluation is necessary but is NOT diagnostic 1
  • Approximately 20% of heterozygous carriers (who do NOT have disease) have decreased ceruloplasmin 1, 2

Normal Levels (≥200 mg/L or ≥20 mg/dL)

  • Does NOT exclude Wilson's disease 1, 2
  • Must proceed with additional diagnostic testing if clinical suspicion remains 2

Essential Follow-Up Testing When Ceruloplasmin is Abnormal OR Clinical Suspicion Remains High

Proceed with this diagnostic algorithm:

  1. 24-hour urinary copper excretion (using copper-free glassware)

    • Values >100 μg/24 hours (>1.6 μmol/24 hours) indicate Wilson's disease 2
  2. Calculate non-ceruloplasmin-bound (free) copper

    • Values >25 μg/dL (250 μg/L) strongly suggest Wilson's disease 2
  3. Slit-lamp examination by experienced ophthalmologist

    • Look for Kayser-Fleischer rings 1
    • Absence does NOT exclude diagnosis, even in neurological disease 1
  4. Consider genetic testing for ATP7B mutations

    • Two pathogenic mutations confirm diagnosis 2
  5. Hepatic copper concentration if liver biopsy performed

    • 4 μmol/g dry weight (>250 μg/g) provides best biochemical evidence 2

Critical Pitfalls to Avoid

False Elevation of Ceruloplasmin

  • Ceruloplasmin is an acute phase reactant and can be falsely elevated by 1, 2:
    • Acute inflammation or infection
    • Pregnancy
    • Estrogen supplementation or oral contraceptives

Assay Limitations

  • Immunologic assays may overestimate ceruloplasmin because they measure both apo- and holoceruloplasmin (only holoceruloplasmin contains copper) 1, 2
  • Enzymatic assays measuring oxidase activity are more specific than immunologic assays 5

Age-Related Variations

  • Ceruloplasmin is physiologically very low in infancy (up to 6 months), peaks above adult levels in early childhood, then normalizes 1, 2
  • Age alone should NEVER exclude Wilson's disease from consideration 1, 2

Other Causes of Low Ceruloplasmin

Low ceruloplasmin occurs in conditions OTHER than Wilson's disease 1, 2:

  • Severe protein loss (nephrotic syndrome, protein-losing enteropathy)
  • End-stage liver disease of any etiology
  • Copper deficiency (parenteral nutrition without trace elements)
  • Menkes disease (X-linked copper transport disorder)
  • Aceruloplasminemia (presents with hemosiderosis, not copper accumulation)

Impact on Morbidity and Mortality

Early diagnosis through appropriate ceruloplasmin testing and comprehensive evaluation is critical because:

  • Wilson's disease is fatal if untreated but has excellent outcomes with early copper chelation therapy 6
  • Delayed diagnosis leads to irreversible neurological damage and end-stage liver disease 4, 6
  • Only 65% of patients presenting with liver disease are diagnosed by typical findings (low ceruloplasmin + Kayser-Fleischer rings), compared to 90% with neurological disease 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach to Suspected Wilson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Wilson's disease: Revisiting an old friend.

World journal of hepatology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.